Seasonal Evaluation for Vertex Pharmaceuticals Incorporated (VRTX)
The following tables show quarterly and semi-annual reports.
In the quarterly breakdown, the first through fourth quarters correspond to spring, summer, fall, and winter, respectively.
Detailed definitions for the semi-annual periods are provided in the table headers.
| Overview | 1st Quarter Jan. - Mar. |
2nd Quarter Apr. - Jun. |
3rd Quarter Jul. - Sep. |
4th Quarter Oct. - Dec. |
|---|---|---|---|---|
| Success Rate | 65.00% | 80.00% | 40.00% | 45.00% |
| Median Return | 8.72% | 8.34% | -0.74% | -0.85% |
| Average Return | 14.20% | 10.49% | 7.95% | 11.62% |
| Maximum Gain | 48.43% | 45.64% | 34.49% | 29.24% |
| Gain Year | 2017 | 2013 | 2007 | 2019 |
| Maximum Loss | -36.83% | -19.50% | -15.66% | -39.52% |
| Loss Year | 2016 | 2010 | 2015 | 2007 |
| Based on the past 20 years (2006-2025) | ||||
| Overview | Winter Season Oct. - Mar. |
Summer Season Apr. - Sep. |
First HY Jan. - Jun. |
Second HY Jul. - Dec. |
|---|---|---|---|---|
| Success Rate | 55.00% | 60.00% | 72.50% | 42.50% |
| Median Return | 2.79% | 3.52% | 8.58% | -0.74% |
| Average Return | 13.08% | 9.56% | 12.01% | 9.72% |
| Maximum Gain | 48.43% | 45.64% | 48.43% | 34.49% |
| Gain Year | 2017 | 2013 | 2017 | 2007 |
| Maximum Loss | -39.52% | -19.50% | -36.83% | -39.52% |
| Loss Year | 2007 | 2010 | 2016 | 2007 |
| Based on the past 20 years (2006-2025) | ||||